DOH Promptly Warns Doctors Of “Off Label” Ivermectin Prescriptions
IVERMECTIN – The Department of Health (DOH) warns doctors that they would be held accountable for “off label” prescriptions of Ivermectin.
The anti-parasitic drug primarily used for animals got a lot of traction in the recent months. According to politicians and other personalities, the drug can be used to combat COVID-19.
However, the DOH warned that prescribing the drug for the purpose of combating COVID-19 could be held accountable as it is still certified for use as an anti-parasitic drug.
Currently, Llyod Laboratories applied for the use of Ivermectin as an “anti-nematode” drug. For those unaware, a Nematode is a type of parasitic worm. According to an article from Inquirer, DOH Undersecretary Maria Rosario Vergeire said:
Kung sakaling gagamitin ‘yang ivermectin ng ibang mga doktor [for other purposes], it’s going to be an off-label use and ang accountability and liability will be resting upon the physician who has prescribed this
On Friday, the FDA approved Llyod Laboratories for the manufacture and sale of “human grade ivermectin”. However, it is only allowed for “anti-nematode” purposes.
Meanwhile, with regards to Ivermectin’s clinical trials for combating COVID-19, the Philippines is set to begin by the end of May or early June. But, results can still be expected around early 2022.
Thanks for reading. We aim to provide our readers with the freshest and most in-demand content. Come back next time for the latest news here on Philnews.